Developer docs
API playgroundTry for free, no card

Search company profiles

Boston IVF

Full company profile

uuid0006vvv

Namestring
Boston IVF
Legal namestring
Boston IVF, LLC
Websiteurl
bostonivf.com
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Boston IVF is a multi-site fertility care network headquartered in Waltham, Massachusetts, founded in 1986 as one of New England's leading infertility treatment centers and now operating 20+ fertility centers and satellite monitoring sites across Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Indiana, North Carolina, Ohio, and Utah, with nearly 30 centers and 40 reproductive endocrinologists in total. The practice delivers assisted reproductive technologies including IVF, ICSI, IUI, ovulation induction, donor egg/sperm/embryo services, gestational carrier coordination, fertility preservation (egg and sperm freezing), oncofertility, and preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), supported by 25+ embryology laboratories (across the IVI RMA North America network), time-lapse embryo incubation, vitrification, and AI-assisted embryo grading. Patient segments span heterosexual couples, single women and men, same-sex couples, transgender and gender-diverse individuals, oncofertility patients, and condition-specific cohorts (PCOS, endometriosis, male factor, recurrent miscarriage, diminished ovarian reserve).

The business operates a fee-for-service revenue model charging per IVF cycle and ancillary service, with pricing not publicly disclosed. Patient access is broadened through financing partnerships with Gaia (value-based milestone plans) and PatientFi (zero-interest financing up to $50,000, terms up to 84 months, no hard credit checks), and through an employer-benefit channel via the Costco + Sesame program. Volume scales to roughly 15,000 IVF cycles per year, 5,000+ eggs frozen annually, and 150,000+ cumulative babies born since 1986, with a database of 875,000+ IVF cycles supporting clinical decision-making. Distribution is hybrid: direct-to-consumer acquisition via website, phone, and patient portal, layered with healthcare-provider referrals through an HCP resource hub and Harvard Medical School-accredited CME programming. Boston IVF is a founding member of IVI RMA North America (owned by Spain's IVI RMA Global) and operates alongside acquired regional brands including Ohio Reproductive Medicine, Reproductive Care Center (Utah), Delaware Institute for Reproductive Medicine, and Wilmington Fertility Center.

Short descriptiontext

Boston IVF is a multi-site fertility care network operating 20+ clinics across 11 US states, delivering IVF, ICSI, fertility preservation, third-party reproduction, and genetic testing to a diversified patient base of couples, singles, LGBTQ+ individuals, and oncofertility patients. It is a founding member of IVI RMA North America, performing ~15,000 IVF cycles per year.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices25 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility treatment services, in vitro fertilization, reproductive endocrinology, egg freezing preservation, third-party reproduction
Industry4 codes
1Fertility, Reproductive Endocrinology & IVF Centers
CodeHLAFAJADPrimaryYes
2Reproductive Endocrinology & Infertility (IVF/Fertility)
CodeHLAKAJACPrimaryNo
3Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryNo
4Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
CodeHLALAHAAPrimaryNo
NAICS code2 codes
  • Ambulatory Health Care Services621
  • Other Ambulatory Health Care Services6219
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Reproductive Healthcare and Fertility Treatment Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Fertility Treatment Services
TypeTransaction Fee
Description

Boston IVF generates revenue primarily through fee-for-service fertility treatment procedures including IVF cycles, IUI, ovulation induction, egg freezing, donor egg IVF, donor sperm, gestational carrier services, and genetic testing. Each treatment cycle represents a discrete billable service. The company also derives revenue from diagnostic services (semen analysis, hormone testing, ultrasound monitoring), consultations, and monitoring visits throughout treatment protocols.

bostonivf.com
2Fertility Financing Partnerships
TypeTransaction Fee
Description

Boston IVF partners with Gaia (value-based financial plans aligned with treatment milestones) and PatientFi (zero-interest financing up to $50,000, flexible terms up to 84 months, no hard credit checks) to make treatments more accessible. These financing arrangements expand the customer base able to pay for fertility services over time.

finance.yahoo.com
3Wellness and Support Services
TypeProfessional Services
Description

Boston IVF offers ancillary services including acupuncture, nutritional counseling, and emotional support therapy through its Wellness Center. These complementary services generate additional per-visit revenue while enhancing the overall patient treatment experience.

bostonivf.com
4Continuing Medical Education (CME)
TypeProfessional Services
Description

Boston IVF delivers CME-accredited webinars (accredited by Harvard Medical School) for medical professionals, awarding AMA PRA Category 1 Credits. While free for attendees, these programs serve as a GTM and referral pipeline from healthcare providers into the practice.

bostonivf.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Egg Freezing Discount Program for Medical Students, Residents & Fellows
ModelUnit PricingBilling cadencePay-as-you-go
Notes

25% discount off one egg freezing cycle. Services included: Cycle Monitoring, Egg Retrieval, Cryopreservation. Eligibility requires proof of medical training/residency/fellowship in the United States, graduation date, and cycle completion within 6 months after graduation.

bostonivf.com
2PatientFi Financing
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Zero-interest financing up to $50,000 with flexible terms up to 84 months and no hard credit checks, through PatientFi.

finance.yahoo.com
3Gaia Value-Based Financial Plans
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Gaia offers value-based financial plans aligned with treatment milestones, designed to make fertility care more accessible with personalized financial structures.

finance.yahoo.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Boston IVF operates a multi-site fertility care network providing assisted reproductive technology services including IVF with ICSI, IUI, ovulation induction, egg and sperm freezing, donor egg/sperm/embryo programs, gestational carrier (surrogacy) services, preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), oncofertility preservation, gynecological surgery, and LGBTQ+ family building. Supporting offerings include a Wellness Center (acupuncture, nutritional counseling, emotional support), telehealth consultations, and fertility financing via Gaia and PatientFi partnerships, delivered across 20+ clinic locations as part of the IVI RMA North America network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 150,000+ babies born since 1986, averaging 11 Boston IVF babies per day
+4 more records
Product overview1 text field

Boston IVF is a multi-site fertility care network offering a comprehensive portfolio of assisted reproductive technology services. The core clinical offerings center on IVF (with ICSI capability), IUI, ovulation induction, and fertility preservation (egg and sperm freezing). The portfolio expands into third-party reproduction through donor egg, donor sperm, donor embryo, and gestational carrier programs. Supporting services include genetic testing (PGT-A, PGT-M, PGT-SR), gynecological surgery, and a dedicated Oncofertility program for cancer patients. Patient support is delivered through an integrated Wellness Center (acupuncture, counseling, nutrition), Telehealth platforms, and comprehensive fertility financing via Gaia and PatientFi partnerships. The organization operates 20+ locations across Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Indiana, North Carolina, Ohio, and Utah, connected as part of the IVI RMA North America network of 25+ IVF laboratories.

Product and service2 records
1In Vitro Fertilization (IVF)
CategoryCore Treatment Service
Description

Primary assisted reproductive technology service involving egg retrieval, laboratory fertilization, embryo culture, and embryo transfer. Includes conventional insemination and ICSI (Intracytoplasmic Sperm Injection) options. For individuals and couples experiencing infertility.

2Intrauterine Insemination (IUI)
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-03
Description

Synergyne ART Analytics announced a research collaboration with Boston IVF to evaluate a Time-Adjusted version of its usER test, which assesses endometrial receptivity for IVF embryo transfer decisions. The study will test whether the diagnostic test can maintain accuracy when performed 4-5 days earlier in the IVF cycle than the standard 48-hour window before transfer. If validated, earlier-cycle testing could reduce patient visits, improve workflow integration, and expand access to the usER test across fertility clinics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

DIRM joined forces with Boston IVF in 2022, ensuring that individuals and couples in the Mid-Atlantic region receive world-class reproductive care close to home. DIRM, Delaware's first fertility treatment center, operates full-service IVF in Newark, DE, monitoring centers in Milford, DE and Chadds Ford, PA, and brought first IVF, FET, donor egg, donor sperm, ICSI, GIFT, ZIFT pregnancies in Delaware, and first pregnancy from a frozen embryo in the Mid-Atlantic.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Ohio Reproductive Medicine joined Boston IVF in 2021. ORM is central Ohio's first and largest IVF program and the first in Ohio to achieve a successful GIFT procedure. The partnership brings world-class care to patients in Ohio with access to Boston IVF's national network and latest advancements in reproductive medicine.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Reproductive Care Center joined Boston IVF in 2021. RCC is Utah's first private practice fertility clinic and has been a leader in fertility care for over 25 years, serving the Intermountain West. RCC operates a full-service IVF center in Sandy, UT and a monitoring center in Clearfield, UT. It was the first in Utah to achieve a live birth from frozen donor oocytes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boston IVF is a founding member of IVI RMA North America, a network of 25+ state-of-the-art IVF laboratories across the US and Canada that has helped welcome 220,000+ babies. The network provides access to 100+ fertility specialists, enables cross-network case consultation, and shares research insights. Boston IVF is united with leading fertility programs including Conceptions Reproductive Associates, Delaware Institute for Reproductive Medicine, Island Reproductive Services, Mid-Iowa Fertility, Ohio Reproductive Medicine, Reproductive Care Center, Reproductive Medicine Associates (RMA), TRIO (Toronto), and Wilmington Fertility Center.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boston IVF maintains an ongoing clinical partnership with Harvard Medical School. This affiliation enables Boston IVF's REI Fellowship Program developed in partnership with Harvard and Beth Israel Deaconess Medical Center, CME webinar accreditation through Harvard Medical School, and collaborative clinical research. Harvard Medical School also sends CME credits annually to Boston IVF's medical education participants.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Boston IVF's REI Fellowship Program was developed in partnership with Beth Israel Deaconess Medical Center and Harvard Medical School. Fellows train at both institutions. Quetrell Heyward, MD, MBA is a Reproductive Endocrinology and Infertility Fellow at both Boston IVF and BIDMC.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Boston IVF partnered with Costco and Sesame to offer a fertility program designed to make high-quality fertility care more accessible and affordable from the beginning of the patient journey. The program provides discounted treatment bundles and concierge support through Costco's employer benefits platform.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CCRM operates a large national network of fertility clinics with full-service IVF labs, PGT, and third-party reproduction services across major US metros. It is the closest head-to-head competitor to Boston IVF in scale, technology stack, and patient demographic.

TypeDirect peer
Description

Shady Grove Fertility, now part of US Fertility/Inception Fertility, is one of the largest US fertility clinic networks with comparable cycle volumes and a multi-state footprint. It directly competes for patients in the Mid-Atlantic and Northeast where Boston IVF is concentrated.

TypeDirect peer
Description

New Hope is a multi-location US fertility clinic offering IVF, egg freezing, and LGBTQ+ family building with a focus on mild/minimal stimulation protocols. It competes with Boston IVF in New York and other Northeast markets for elective egg freezing and IVF patients.

TypeEmerging player
Description

Extend Fertility specializes in elective egg freezing with dedicated clinics in major US cities, including New York. It is a more focused, single-service competitor that overlaps with Boston IVF's egg-freezing service line rather than its full IVF offering.

TypeDirect peer
Description

Prelude Fertility operates a national network of fertility clinics including MyEggBank and network partner practices. It competes directly with Boston IVF in IVF, egg freezing, and third-party reproduction across multiple US geographies.

TypeDirect peer
Description

Pacific Fertility Center is a full-service IVF clinic in San Francisco offering IVF, PGT, egg freezing, and LGBTQ+ family building. It is comparable in clinical scope though smaller and geographically distinct from Boston IVF.

TypeBroad incumbent
Description

Columbia's fertility center is a New York-based academic reproductive medicine practice offering IVF, ICSI, PGT, and fertility preservation. It competes for NYC patients and brings academic reputation comparable to Boston IVF's Harvard/BIDMC affiliation.

TypeBroad incumbent
Description

Weill Cornell's reproductive medicine program is an academic New York fertility center offering full-service IVF, PGT, and LGBTQ+ care. It overlaps with Boston IVF in the NYC market and shares the academic-medical-center positioning.

TypeEmerging player
Description

CNY Fertility is a multi-state fertility clinic known for significantly lower cash-pay IVF pricing and destination-medicine positioning. It competes on affordability rather than brand prestige, drawing cost-sensitive patients who might otherwise consider Boston IVF.

TypeDirect peer
Description

RMANJ is a large multi-physician fertility practice with strong clinical research output and full-service IVF, PGT, and third-party reproduction. It is a direct Northeast competitor and a comparable academic-adjacent practice to Boston IVF.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment11 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Boston IVF

Reproductive Healthcare and Fertility Treatment Servicesbostonivf.com

Boston IVF is a multi-site fertility care network operating 20+ clinics across 11 US states, delivering IVF, ICSI, fertility preservation, third-party reproduction, and genetic testing to a diversified patient base of couples, singles, LGBTQ+ individuals, and oncofertility patients. It is a founding member of IVI RMA North America, performing ~15,000 IVF cycles per year.

What Boston IVF does

Boston IVF is a multi-site fertility care network headquartered in Waltham, Massachusetts, founded in 1986 as one of New England's leading infertility treatment centers and now operating 20+ fertility centers and satellite monitoring sites across Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Indiana, North Carolina, Ohio, and Utah, with nearly 30 centers and 40 reproductive endocrinologists in total. The practice delivers assisted reproductive technologies including IVF, ICSI, IUI, ovulation induction, donor egg/sperm/embryo services, gestational carrier coordination, fertility preservation (egg and sperm freezing), oncofertility, and preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), supported by 25+ embryology laboratories (across the IVI RMA North America network), time-lapse embryo incubation, vitrification, and AI-assisted embryo grading. Patient segments span heterosexual couples, single women and men, same-sex couples, transgender and gender-diverse individuals, oncofertility patients, and condition-specific cohorts (PCOS, endometriosis, male factor, recurrent miscarriage, diminished ovarian reserve).

The business operates a fee-for-service revenue model charging per IVF cycle and ancillary service, with pricing not publicly disclosed. Patient access is broadened through financing partnerships with Gaia (value-based milestone plans) and PatientFi (zero-interest financing up to $50,000, terms up to 84 months, no hard credit checks), and through an employer-benefit channel via the Costco + Sesame program. Volume scales to roughly 15,000 IVF cycles per year, 5,000+ eggs frozen annually, and 150,000+ cumulative babies born since 1986, with a database of 875,000+ IVF cycles supporting clinical decision-making. Distribution is hybrid: direct-to-consumer acquisition via website, phone, and patient portal, layered with healthcare-provider referrals through an HCP resource hub and Harvard Medical School-accredited CME programming. Boston IVF is a founding member of IVI RMA North America (owned by Spain's IVI RMA Global) and operates alongside acquired regional brands including Ohio Reproductive Medicine, Reproductive Care Center (Utah), Delaware Institute for Reproductive Medicine, and Wilmington Fertility Center.

Boston IVF firmographics

Firmographics
Name
Boston IVF
Legal name
Boston IVF, LLC
Website
https://bostonivf.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
251–500 employees
Short description
Boston IVF is a multi-site fertility care network operating 20+ clinics across 11 US states, delivering IVF, ICSI, fertility preservation, third-party reproduction, and genetic testing to a diversified patient base of couples, singles, LGBTQ+ individuals, and oncofertility patients. It is a founding member of IVI RMA North America, performing ~15,000 IVF cycles per year.
Ownership category
akta.pro rank

Boston IVF industry classification

Industry
Product category
Reproductive Healthcare and Fertility Treatment Services
NAICS
Ambulatory Health Care Services (621), Other Ambulatory Health Care Services (6219)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
akta.pro secondary industries
Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

Keywords

  • Fertility treatment services
  • In vitro fertilization
  • Reproductive endocrinology
  • Egg freezing preservation
  • Third-party reproduction

Where Boston IVF is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices25 records

Markets served

Boston IVF business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Fertility Treatment Services: Boston IVF generates revenue primarily through fee-for-service fertility treatment procedures including IVF cycles, IUI, ovulation induction, egg freezing, donor egg IVF, donor sperm, gestational carrier services, and genetic testing. Each treatment cycle represents a discrete billable service. The company also derives revenue from diagnostic services (semen analysis, hormone testing, ultrasound monitoring), consultations, and monitoring visits throughout treatment protocols.
  2. Fertility Financing Partnerships: Boston IVF partners with Gaia (value-based financial plans aligned with treatment milestones) and PatientFi (zero-interest financing up to $50,000, flexible terms up to 84 months, no hard credit checks) to make treatments more accessible. These financing arrangements expand the customer base able to pay for fertility services over time.
  3. Wellness and Support Services: Boston IVF offers ancillary services including acupuncture, nutritional counseling, and emotional support therapy through its Wellness Center. These complementary services generate additional per-visit revenue while enhancing the overall patient treatment experience.
  4. Continuing Medical Education (CME): Boston IVF delivers CME-accredited webinars (accredited by Harvard Medical School) for medical professionals, awarding AMA PRA Category 1 Credits. While free for attendees, these programs serve as a GTM and referral pipeline from healthcare providers into the practice.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goEgg Freezing Discount Program for Medical Students, Residents & Fellows
Transaction based/ take ratePay-as-you-goPatientFi Financing
Outcome Based/ PerformanceMulti-year contractGaia Value-Based Financial Plans

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Boston IVF product offering

Product offering

Core offering

Boston IVF operates a multi-site fertility care network providing assisted reproductive technology services including IVF with ICSI, IUI, ovulation induction, egg and sperm freezing, donor egg/sperm/embryo programs, gestational carrier (surrogacy) services, preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), oncofertility preservation, gynecological surgery, and LGBTQ+ family building. Supporting offerings include a Wellness Center (acupuncture, nutritional counseling, emotional support), telehealth consultations, and fertility financing via Gaia and PatientFi partnerships, delivered across 20+ clinic locations as part of the IVI RMA North America network.

Product overview

Boston IVF is a multi-site fertility care network offering a comprehensive portfolio of assisted reproductive technology services. The core clinical offerings center on IVF (with ICSI capability), IUI, ovulation induction, and fertility preservation (egg and sperm freezing). The portfolio expands into third-party reproduction through donor egg, donor sperm, donor embryo, and gestational carrier programs. Supporting services include genetic testing (PGT-A, PGT-M, PGT-SR), gynecological surgery, and a dedicated Oncofertility program for cancer patients. Patient support is delivered through an integrated Wellness Center (acupuncture, counseling, nutrition), Telehealth platforms, and comprehensive fertility financing via Gaia and PatientFi partnerships. The organization operates 20+ locations across Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Indiana, North Carolina, Ohio, and Utah, connected as part of the IVI RMA North America network of 25+ IVF laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vitro Fertilization (IVF) Primary assisted reproductive technology service involving egg retrieval, laboratory fertilization, embryo culture, and embryo transfer. Includes conventional insemination and ICSI (Intracytoplasmic Sperm Injection) options. For individuals and couples experiencing infertility.
  • Intrauterine Insemination (IUI)

Quantifiable outcome

  • 150,000+ babies born since 1986, averaging 11 Boston IVF babies per day
  • +4 more outcomes

Companies that use Boston IVF

Customer profile

Named customers10 records

Segments11 records

Ideal customer profiles4 records

Boston IVF technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Boston IVF partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Synergyne ART AnalyticscoreStrategic or Co-development Partner · 3 March 2026Synergyne ART Analytics announced a research collaboration with Boston IVF to evaluate a Time-Adjusted version of its usER test, which assesses endometrial receptivity for IVF embryo transfer decisions. The study will test whether the diagnostic test can maintain accuracy when performed 4-5 days earlier in the IVF cycle than the standard 48-hour window before transfer. If validated, earlier-cycle testing could reduce patient visits, improve workflow integration, and expand access to the usER test across fertility clinics.
  • Delaware Institute for Reproductive Medicine (DIRM)coreStrategic or Co-development Partner · 1 January 2022DIRM joined forces with Boston IVF in 2022, ensuring that individuals and couples in the Mid-Atlantic region receive world-class reproductive care close to home. DIRM, Delaware's first fertility treatment center, operates full-service IVF in Newark, DE, monitoring centers in Milford, DE and Chadds Ford, PA, and brought first IVF, FET, donor egg, donor sperm, ICSI, GIFT, ZIFT pregnancies in Delaware, and first pregnancy from a frozen embryo in the Mid-Atlantic.
  • Ohio Reproductive Medicine (ORM)coreStrategic or Co-development Partner · 1 January 2021Ohio Reproductive Medicine joined Boston IVF in 2021. ORM is central Ohio's first and largest IVF program and the first in Ohio to achieve a successful GIFT procedure. The partnership brings world-class care to patients in Ohio with access to Boston IVF's national network and latest advancements in reproductive medicine.
  • Reproductive Care Center (RCC)coreStrategic or Co-development Partner · 1 January 2021Reproductive Care Center joined Boston IVF in 2021. RCC is Utah's first private practice fertility clinic and has been a leader in fertility care for over 25 years, serving the Intermountain West. RCC operates a full-service IVF center in Sandy, UT and a monitoring center in Clearfield, UT. It was the first in Utah to achieve a live birth from frozen donor oocytes.
  • IVI RMA North AmericacoreStrategic or Co-development PartnerBoston IVF is a founding member of IVI RMA North America, a network of 25+ state-of-the-art IVF laboratories across the US and Canada that has helped welcome 220,000+ babies. The network provides access to 100+ fertility specialists, enables cross-network case consultation, and shares research insights. Boston IVF is united with leading fertility programs including Conceptions Reproductive Associates, Delaware Institute for Reproductive Medicine, Island Reproductive Services, Mid-Iowa Fertility, Ohio Reproductive Medicine, Reproductive Care Center, Reproductive Medicine Associates (RMA), TRIO (Toronto), and Wilmington Fertility Center.
  • Harvard Medical SchoolcoreStrategic or Co-development PartnerBoston IVF maintains an ongoing clinical partnership with Harvard Medical School. This affiliation enables Boston IVF's REI Fellowship Program developed in partnership with Harvard and Beth Israel Deaconess Medical Center, CME webinar accreditation through Harvard Medical School, and collaborative clinical research. Harvard Medical School also sends CME credits annually to Boston IVF's medical education participants.
  • Beth Israel Deaconess Medical Center (BIDMC)coreStrategic or Co-development PartnerBoston IVF's REI Fellowship Program was developed in partnership with Beth Israel Deaconess Medical Center and Harvard Medical School. Fellows train at both institutions. Quetrell Heyward, MD, MBA is a Reproductive Endocrinology and Infertility Fellow at both Boston IVF and BIDMC.
  • Costco and SesameminorGTM or Marketing PartnerBoston IVF partnered with Costco and Sesame to offer a fertility program designed to make high-quality fertility care more accessible and affordable from the beginning of the patient journey. The program provides discounted treatment bundles and concierge support through Costco's employer benefits platform.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Boston IVF competitors and assessment

Company assessment

Direct peers

  • CCRM Fertility: CCRM operates a large national network of fertility clinics with full-service IVF labs, PGT, and third-party reproduction services across major US metros. It is the closest head-to-head competitor to Boston IVF in scale, technology stack, and patient demographic.
  • Shady Grove Fertility (US Fertility): Shady Grove Fertility, now part of US Fertility/Inception Fertility, is one of the largest US fertility clinic networks with comparable cycle volumes and a multi-state footprint. It directly competes for patients in the Mid-Atlantic and Northeast where Boston IVF is concentrated.
  • New Hope Fertility Center: New Hope is a multi-location US fertility clinic offering IVF, egg freezing, and LGBTQ+ family building with a focus on mild/minimal stimulation protocols. It competes with Boston IVF in New York and other Northeast markets for elective egg freezing and IVF patients.
  • Prelude Fertility: Prelude Fertility operates a national network of fertility clinics including MyEggBank and network partner practices. It competes directly with Boston IVF in IVF, egg freezing, and third-party reproduction across multiple US geographies.
  • Pacific Fertility Center: Pacific Fertility Center is a full-service IVF clinic in San Francisco offering IVF, PGT, egg freezing, and LGBTQ+ family building. It is comparable in clinical scope though smaller and geographically distinct from Boston IVF.
  • Reproductive Medicine Associates of New Jersey (RMANJ): RMANJ is a large multi-physician fertility practice with strong clinical research output and full-service IVF, PGT, and third-party reproduction. It is a direct Northeast competitor and a comparable academic-adjacent practice to Boston IVF.

Emerging players

  • Extend Fertility: Extend Fertility specializes in elective egg freezing with dedicated clinics in major US cities, including New York. It is a more focused, single-service competitor that overlaps with Boston IVF's egg-freezing service line rather than its full IVF offering.
  • CNY Fertility: CNY Fertility is a multi-state fertility clinic known for significantly lower cash-pay IVF pricing and destination-medicine positioning. It competes on affordability rather than brand prestige, drawing cost-sensitive patients who might otherwise consider Boston IVF.

Broad incumbents

  • Columbia University Fertility Center: Columbia's fertility center is a New York-based academic reproductive medicine practice offering IVF, ICSI, PGT, and fertility preservation. It competes for NYC patients and brings academic reputation comparable to Boston IVF's Harvard/BIDMC affiliation.
  • Weill Cornell Medicine - Center for Reproductive Medicine: Weill Cornell's reproductive medicine program is an academic New York fertility center offering full-service IVF, PGT, and LGBTQ+ care. It overlaps with Boston IVF in the NYC market and shares the academic-medical-center positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Boston IVF social profiles

Digital presence

Boston IVF compliance and trust

Trust signal

Compliance4 records

Boston IVF financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Boston IVF leadership team

Management profile

Number of profiles

Profiles3 records

Boston IVF subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Boston IVF funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Boston IVF M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston IVF

What does Boston IVF do?

Boston IVF operates a multi-site fertility care network providing assisted reproductive technology services including IVF with ICSI, IUI, ovulation induction, egg and sperm freezing, donor egg/sperm/embryo programs, gestational carrier (surrogacy) services, preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), oncofertility preservation, gynecological surgery, and LGBTQ+ family building. Supporting offerings include a Wellness Center (acupuncture, nutritional counseling, emotional support), telehealth consultations, and fertility financing via Gaia and PatientFi partnerships, delivered across 20+ clinic locations as part of the IVI RMA North America network.

Is Boston IVF a public or private company?

Boston IVF is a private company. It is classified as corporate owned and is currently operating.

When was Boston IVF founded?

Boston IVF was founded in 1986. It employs 251 to 500 people.

Where is Boston IVF based?

Boston IVF is headquartered in Waltham, United States, in the North America region.

How does Boston IVF make money?

Four revenue lines are on record. Fertility Treatment Services are the primary driver. The others are fertility Financing Partnerships, wellness and Support Services and continuing Medical Education (CME).

Who are Boston IVF's main competitors?

Direct peers on record are CCRM Fertility, Shady Grove Fertility (US Fertility), New Hope Fertility Center, Prelude Fertility, Pacific Fertility Center and Reproductive Medicine Associates of New Jersey (RMANJ). Emerging players are Extend Fertility and CNY Fertility. Broad incumbents are Columbia University Fertility Center and Weill Cornell Medicine - Center for Reproductive Medicine.

Does Boston IVF have an API?

No public API is recorded for Boston IVF.

What industry is Boston IVF in?

Boston IVF's product category is Reproductive Healthcare and Fertility Treatment Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogBoston IVF Expands Fertility Care in Maine with Reproductive Endocrinologist and Former Boston IVF Fellow Dr. Alexandra HuttlerBoston IVF announced that reproductive endocrinologist Dr. Alexandra Huttler has joined its Maine care team, seeing patients at The Portland, M Fertility Center. She completed her fellowship at Boston IVF and has published peer-reviewed papers on IVF ethics and outcomes. She will provide telehealth and in-person appointments.EIN PresswireSynergyne ART Analytics Announces Study With Boston IVF to Evaluate Time-Adjusted usER Test for Embryo Transfer DecisionSynergyne ART Analytics announced a research collaboration with Boston IVF to evaluate a Time-Adjusted version of its usER test, which assesses endometrial receptivity for IVF embryo transfer decisions. The study will test whether the diagnostic test can maintain accuracy when performed 4-5 days earlier in the IVF cycle than the standard 48-hour window before transfer. If validated, earlier-cycle testing could reduce patient visits, improve workflow integration, and expand access to the usER test across fertility clinics.HomepageBoston IVF Partners with Gaia and PatientFi to Offer Fertility Treatment FinancingBoston IVF has partnered with Gaia and PatientFi to offer financing options for fertility treatments, enhancing their existing collaborations with IVI RMA North America. Gaia will provide personalized financial plans and protections for patients, while PatientFi offers flexible payment options including zero-interest plans and funding up to $50,000. These partnerships aim to improve access to fertility care across North America, particularly in the Northeast and Boston region.Business Wire BlogBoston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More AccessibleBoston IVF announced new partnerships with Gaia and PatientFi to offer innovative financing options for fertility treatments, expanding access to care across the Northeast. Gaia provides value-based financial plans aligned with treatment milestones, while PatientFi offers zero-interest financing up to $50,000 with flexible terms up to 84 months and no hard credit checks. The collaborations extend existing partnerships between Gaia, PatientFi, and IVI RMA North America, Boston IVF's parent company, which operates more than 24 IVF laboratories across the U.S. and Canada.YahooBoston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More AccessibleBoston IVF announced new partnerships with Gaia and PatientFi to expand innovative financing options for fertility treatment, building on existing partnerships within the IVI RMA North America network. Gaia offers value-based financial plans aligned with treatment milestones, while PatientFi provides zero-interest financing up to $50,000 with flexible terms up to 84 months and no hard credit checks. The collaborations aim to make fertility care more accessible to patients throughout the Northeast, particularly in the Boston region.GlobeNewswireFemasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateFemasys reported Q3 2024 sales of $554,908, up 127.1% year-over-year, with a net loss of $5.4 million. The company announced partnerships with Boston IVF and Spain distributors, and received FDA 510(k) clearance for FemChec. It expects existing cash to fund operations into July 2025.PR NewswireBoston IVF Announces New CEOBoston IVF appointed David Stern as its new CEO effective January 6, 2020, bringing over 25 years of women's health industry experience including prior CEO roles at Symbiomix Therapeutics and senior leadership positions at Merck Serono and EMD Serono. Boston IVF is described as one of the country's largest fertility practices with over 90,000 babies born since 1986 and 25+ locations across the United States. Eugin Group, which acquired a majority stake in Boston IVF in 2019, stated that Stern's appointment represents an important moment for their corporate and clinical strategy in New England and throughout North America.PR NewswireBoston IVF Announces Results of Landmark Transgender Male Fertility Research StudyBoston IVF announced results from its landmark 8-year clinical study showing that transgender men who had begun testosterone hormone therapy achieved similar egg yields through fertility preservation as cisgender female patients, challenging previous medical assumptions that transition therapy must precede egg freezing. The study, the largest of its kind, found that patients on long-term gender-affirming androgen therapy did not show negative effects on ovarian stimulation outcomes, potentially expanding reproductive options for transgender individuals. Researchers hope these findings will assist healthcare providers in better counseling transgender patients about fertility preservation options.BioSpaceNMC Health PLC Acquires Boston IVF to Create the Most Diversified and Experienced Fertility Network in the WorldNMC Health plc, a London Stock Exchange-listed healthcare company, has acquired a majority stake in Boston IVF, one of the leading fertility services providers in the United States with 29 locations across New England, New York, Indiana, and Arizona. The acquisition creates what NMC describes as the most diversified and experienced fertility network globally, serving as a platform for NMC to expand its IVF business into the North American market. Boston IVF, which has facilitated over 90,000 births since 1986, will continue to operate under its existing leadership while leveraging NMC's European expertise in assisted reproduction technology.PR NewswireNMC Health PLC Acquires Boston IVF to Create the Most Diversified and Experienced Fertility Network in the WorldNMC Health plc has acquired a majority stake in Boston IVF, a leading fertility services provider in the United States, to expand its international network and growth in North America. This strategic move combines NMC's European expertise with Boston IVF's extensive clinic network and research capabilities to enhance patient care and innovation in assisted reproduction.